Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
ETFMG Treatments, Testing and Advancements ETF GERM
$20.49
-$0.04 (-0.22%)
На 18:02, 12 мая 2023
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
27.55
-
week52low
17.74
-
Revenue
-
P/E TTM
-
Beta
0.00000000
-
EPS
2.57302740
-
Last Dividend
0.22900000
-
Next Earnings Date
07 мая 2023 г. в 03:46
Описание компании
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Can Health Care Stocks Outperform Again In 2023?
Seeking Alpha
11 янв 2023 г. в 18:09
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
Here's Why COVID-Themed ETFs May Come Back Under the Radar
Zacks Investment Research
26 окт 2022 г. в 14:18
COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.
Biotech ETFs Slip After Novavax Cuts 2022 Guidance
ETF Trends
11 авг 2022 г. в 08:39
Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Genomics Immunology and Healthcare ETF (IDNA) fell 4.1%, ETFMG Treatments Testing and Advancements ETF (GERM) dropped 4.3%, SPDR S&P Biotech ETF (XBI) decreased 3.
Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs
ETF Trends
03 авг 2022 г. в 18:23
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in its latest quarterly report, along with a share buyback plan. On Wednesday, the Invesco Nasdaq Biotechnology ETF (IBBQ) increased 4.2%, the ETFMG Treatments Testing and Advancements ETF (GERM) advanced 5.
Pharma & Biotech ETFs at One-Month High: Here's Why
Zacks Investment Research
08 июл 2022 г. в 09:20
Pharma and biotech ETFs are in great shape and are trading at a one-month high level.